Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
"Observational Study on Tolerability and Observance of Post-exposure Prophylaxis With Doravirine in HIV Viral Risk"
- Status
- COMPLETED
- Phase
- N/A
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology
- Status
- RECRUITING
- Phase
- PHASE2
Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Vaccinations and People With Disabilities
- Status
- RECRUITING
- Phase
- N/A
Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Assessment of the Efficacy and Safety of Pembrolizumab for Ovarian Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
REPOSE Study: Reducing Delirium by Enhancing Postoperative Sleep With Suvorexant
- Status
- COMPLETED
- Phase
- PHASE2
DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study
- Status
- COMPLETED
- Phase
- PHASE4
Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC
- Status
- RECRUITING
- Phase
- PHASE2
A Multicomponent Clinic-based Intervention to Promote COVID-19 Vaccine Intention and Uptake Among Diverse Youth and Adolescents
- Status
- COMPLETED
- Phase
- NA
A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
ATP and P2X3 Receptor in Chronic Cough
- Status
- UNKNOWN
- Phase
- NA
Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Bridging Study Between V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) to Butantan Dengue Vaccine (Butantan - DV) in Healthy Adults 18 to 50 Years of Age in Brazil (V181 - 002)
- Status
- COMPLETED
- Phase
- PHASE2
An Electronic Health Record-based Approach to Increase PrEP Knowledge and Uptake: the EMC2 PrEP Strategy
- Status
- COMPLETED
- Phase
- NA
IMM60 and Pembrolizumab in Melanoma and NSCLC
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2